Black Rock Inc. Keros Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,513,244 shares of KROS stock, worth $29.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,513,244
Previous 2,166,010
16.03%
Holding current value
$29.3 Million
Previous $143 Million
19.9%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding KROS
# of Institutions
177Shares Held
31.1MCall Options Held
646KPut Options Held
670K-
Vanguard Group Inc Valley Forge, PA1.96MShares$22.8 Million0.0% of portfolio
-
Braidwell LP Stamford, CT1.89MShares$22.1 Million1.68% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$19.7 Million2.53% of portfolio
-
State Street Corp Boston, MA1.2MShares$14 Million0.0% of portfolio
-
Holocene Advisors, LP New York, NY1.2MShares$14 Million0.07% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $301M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...